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doi:10.1016/j.canceXp11.2 translocation-associated renal cell carcinoma (RCC) is a rare tumor that accounts for at
least one-third of childhood RCC. Different reports have emphasized that previous radio/chemo-
therapy might be involved in its pathogenesis. We describe a child who developed a t(X;1)
(p11.2;p34) associated RCC after previous treatment for genitourinary rhabdomyosarcoma in
infancy. The presence of the PSF-TFE3 fusion has only been described in a very limited number
of cases. Our report expands the spectrum of tumors in which RCC can arise in the pediatric age
group after chemotherapy.
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ª 2011 Elsevier Inc. Open access under the Elsevier OA license. Haudebourg et al. (1) described their cytogenetic findings in a
novel case of Xp11.2-associated renal cell carcinoma (RCC)
in a 57-year-old woman.We illustrate a new case of a 13-year-
old boy who developed a RCC harboring the same excep-
tionally rare (X;1)(p11.2;p34) translocation 11 years after
treatment for a primary genitourinary rhabdomyosarcoma.
Patient
A previously healthy 1-year-old infant was referred to a pedi-
atric oncologic center elsewhere for abdominal enlargement.
The diagnosis of an embryonal genitourinary rhabdomyosar-
coma was established through a biopsy sample taken from
a large solid tumor that occupied the lower abdomen, most
probably a primary tumor in the genitourinary tract. The patient
was treated with ifosfamide plus vincristine, actinomycin,
cyclophosphamide, and Adriamycin, as well as brachyther-
apy. The patient was lost to follow-up until 10 years later, when
the family moved to the area served by our institution.st 15, 2010; received in revised form September
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Open access under the Elsevier OA license. At the age of 13 years, the patient was admitted for
abdominal and lumbar pain that had lasted for 1 week. The
clinical examination revealed nothing remarkable. Urinary
analysis depicted microscopic hematuria. Abdominal
computer tomography scan depicted a round, apparently
well-circumscribed mass occupying the lower pole of the
right kidney. The lesion measured 4.2  3.7  3.2 cm, with
heterogeneous contrast enhancement. Chest computed
tomography and bone scintigraphy revealed no evidence of
metastatic disease.
The child underwent a right radical nephrectomy. The
specimen measured 9  5  4 cm and weighed 103 g. When
the specimen was sectioned, in the lower pole of the kidney,
a well-circumscribed, nonencapsulated, tan-colored tumor
measuring 3.5 cm in diameter was discovered with necrotic
hemorrhagic areas. There was no evidence of perirenal fat
involvement, or involvement of the renal vein. Histological
examination showed well-differentiated RCC with clear-cell
features. Areas of eosinophilic differentiation were common
(Figure 1a). Papillary architecture and psammoma bodies
were rarely found. The tumor cells were large with discrete
cell borders and had abundant granular, finely vacuolated
cytoplasm (Figure 1b). The nuclei were slightly enlarged with
mild contour irregularities, and had fine chromatin with
Figure 1 (a) Xp11.2 translocation-associated renal cell carcinoma with clear-cell features showing nests of malignant cells with
intervening thin-walled vessels. The cells demonstrate granular eosinophilic cytoplasm. (b) Nuclei are round to slightly irregular with
mildly enlarged nucleoli visible (Fuhrman grade 2). Hematoxylin and eosin stain (20 objective and 40 objective). (c) Partial inverted
40,6-diamidino-2-phenylindole karyotype showing the t(X;1)(p11.2;p34). (d,e) Representative images showing normal chromosomes
X and 1 and the translocated derivatives after hybridization to SKY probe mixture (d), and chromosome 1 paint WCP1 (red Plati-
nunBright550 labeled, Kreatech Diagnostics) (e). (f) Positivity for the PSF-TFE3 fusion gene: weight marker (lane 1), tumor sample
(lane 2), negative normal kidney sample (lane 3), and blank (lane 4).
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separated by a delicate branching network of vascular tissue
(Figure 1a). Abundant areas of central necrosis and hemor-
rhage were present. There was no evidence of angiolym-
phatic invasion, and all surgical resection margins were free
of tumor. The diagnosis was RCC, stage pT1a cN0 cM0,
Fuhrman grade 2. No adjuvant treatment was delivered, and
the child remained free of disease at 9 months’ follow-up.
After short-term culture of the tumor sample, cytogenetic
analysis by GTG banding denoted a 46,Y,t(X;1)(p11.2;p34)
[17]/46,XY[3] karyotype. The translocation involving chromo-
somes X and 1 was confirmed by means of the SKY probe
mixture (Applied Spectral Imaging, Migdal Ha’Emek, Israel)
and by fluorescence in situ hybridization analysis with specific
probes (Kreatech Diagnostics, Amsterdam, The Netherlands)
(Figure 1cee). Qualitative reverse transcriptaseepolymerasechain reaction for the detection of the t(X;1)(p11.2;p34)
was performed according to Clark et al. (2). Positivity for PSF-
TFE3 chimeric transcripts (Figure 1f) provided a diagnosis
of an Xp11.2-associated RCC.Discussion
Individuals with a history of childhood cancer have a 20-fold
greater risk of developing another malignancy within the first
20 years after treatment (3). RCC occurring as a secondary
malignancy is unusual. The best-characterized secondary
RCCs are those arising in long-term survivors of childhood
neuroblastoma, which were also recognized as a distinctive
subtype in the 2004 World Health Organization classification
of renal tumors (4).
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setting of prior chemotherapy have been described,
including sporadic cases of acute promyelocytic leukemia,
acute myeloid leukemia with t(9;11), bilateral Wilms tumor,
systemic lupus erythematosus, conditioning regimen of
bone marrow transplant for Hurler syndrome (5), sup-
ratentorial primitive neuroectodermal tumor, acute lym-
phoblastic leukemia (6), cardiac leiomyosarcoma (7),
ganglioneuroblastoma (8), and Ewing sarcoma (9). The
present report of a t(X;1)(p11.2;p34)-associated RCC
occurring in a 13-year-old previously treated for genitouri-
nary cancer at the age of 1 year expands the spectrum of
tumors in which RCC can arise in the pediatric age group
after chemotherapy.
Argani et al. (5) reported that 15% of translocation
RCCs were associated with previous exposure to either
topoisomerase II inhibitors or alkylating agents in childhood
and recommended that translocation RCCs should be added
to the list of chemotherapy-associated secondary neoplasms
in children, which includes acute leukemias, soft tissue
sarcomas, and malignant gliomas.
The susceptibility of specific genes to mutagenic or carci-
nogenic agents is widely accepted for leukemia. Indeed,
although translocations might be formed by different mecha-
nisms, several studies have mapped specific chromatin
structural elements, such as in vivo topoisomerase II cleavage
sites, DNAse I hypersensitive sites, and scaffold attachment
regions in the breakpoint regions of relevant genes (including,
e.g., MLL, AF4, AML1, RARA, TEL, BCR, and ABL) that are
probably associated with preferential breakage after exposure
to damage including topoisomerase II inhibitors (10). Other
mechanisms, such as illegitimate recombination mediated
by Alu repeats and long interspersed nuclear elements or
illegitimate V(D)J recombination, have also been proposed to
participate in the formation of gene fusions in lymphoid
malignancies (11,12).
There is still no evidence demonstrating damage-
susceptible regions for genes associated with RCC. Our
patient received both chemotherapy and radiotherapy for
treatment of his primary genitourinary rhabdomyosarcoma at
a very young age. The relation between previous exposure to
carcinogenic substances for oncologic treatment and the
development of secondary RCC in children may be debat-
able. Nevertheless, the case described herein seems to
reinforce this association, supporting the growing body of
evidence that points to the occurrence of secondary RCCs in
children as well as in adults.
Although Xp11-associated renal carcinomas account for
about 40% of pediatric RCC and 4% of adult RCC (13), the t
(X;1)(p11.2;p34) has been described in a small number (nZ
10) of cases (reviewed in Haudebourg et al. (1)), with only
four cases (including the present) appearing in children.
Despite the translocation partner, several studies have
demonstrated that in every case, the DNA-binding domain
of TFE3 is retained. Functional studies have demon-
strated that PSF-TFE3 is essential for growth, invasion,
proliferation, and survival in RCC cells, suggesting that
the chimera plays a key role in the initiation and mainte-
nance of transformed phenotype during tumor develop-
ment and progression (14).
Information regarding the clinical behavior of pediatric
RCC remains controversial because of their exceptionallyrare incidence, especially for rare cases with PSF-TFE3.
Because the morphologic features of Xp11.2 translocation
carcinomas most closely resemble clear-cell renal carci-
nomas, more attention should be paid to cytogenetic and
molecular analysis to obtain the correct diagnosis in these
rare clinical situations of secondary renal tumors in children
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